Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074)

✍ Scribed by Patricia Pautier; Florence Joly; Pierre Kerbrat; Philippe Bougnoux; Pierre Fumoleau; Thierry Petit; Olivier Rixe; François Ringeisen; Annie Tisseron Carrasco; Catherine Lhommé

• Book ID: 113962308
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 283 KB
• Volume: 116
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2009.10.076